Raymond M Reilly

27PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 15, 2026
Panitumumab labeled with Auger electron-emitting <sup>197g</sup>Hg/<sup>197m</sup>Hg: cytotoxicity on human breast cancer cells and tumour and normal tissue uptake in mice with EGFR-overexpressing breast cancer xenografts.

|May 01, 2026
Ion Beam Imaging Shows Selective Thallium-201 Uptake in Cell Nuclei: Impact on Cellular Dosimetry and Radiotoxicity of Auger Electron Emitters.

|Oct 21, 2025
Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [<sup>64</sup>Cu]Cu-DOTA-Panitumumab F(ab')<sub>2</sub> and [<sup>177</sup>Lu]Lu-DOTA-Panitumumab F(ab')<sub>2</sub>.

Meysam Khosravifarsani, Conrad Chan, Anthony Ku

|Jul 17, 2025
Auger electron-emitting EGFR-targeted and non-targeted [<sup>197</sup>Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM).

Madeline K Brown, Zhongli Cai, Constantine J Georgiou

|Dec 16, 2024
Synthesis and Characterization of Thallium-Texaphyrin Nanoparticles and Their Assessment as Potential Delivery Systems for Auger Electron-Emitting <sup>201</sup>Tl to Cancer Cells.

Katarzyna M Wulfmeier, Miffy H Y Cheng, Zhongli Cai

|Dec 12, 2024
Preclinical Comparison of [<sup>111</sup>In]In- and [<sup>225</sup>Ac]Ac-DOTA-Trastuzumab IgG, F(ab')<sub>2</sub> and Fab for Theranostic SPECT/CT Imaging and α-Particle Radioimmunotherapy of HER2-Positive Human Breast Cancer.

Misaki Kondo, Zhongli Cai, Conrad Chan

Pageof 5

Frequent Collaborators

10 joint publications

Mitchell A Winnik

8 joint publications

Zhongli Cai

3 joint publications

Constantine J Georgiou

3 joint publications

Valerie J Facca